NGL Fine-Chem Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: NGLFINE BSE: 524774

About NGL Fine-Chem Limited

No company profile on record yet.

Key facts

BSE symbol524774
NSE symbolNGLFINE
ISININE887E01022
CINL24110MH1981PLC025884
Listing date8 Jul 2022
Fiscal year end31 Mar
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
AuditorHSPN & ASSOCIATES LLP (MR. HEMANT SHETYE)
Registered office301 E-SQUARE, SUBHASH ROAD, VILE PARLE EAST, MUMBAI 400057.
Registrar & transfer agentPURVA SHAREGISTRY (INDIA) P LTD (BUSICOMP SOFTWARE CONSULTANTS UNIT NO.9 SHIV SHAKTI INDL ESTATE, J.R. BORICHA MARG, OPP. KASTURBA HOSPITAL, LOWER PAREL, MUMBAI 400011

Financial performance

Full financials →
Fiscal yearMar 26Mar 25Mar 24Mar 23Mar 22
Total income (before exceptional items)505†370†345†288†330†
Net profit4218392052†

₹ Crore. † Summed from the four quarterly filings of that fiscal year.

Board of directors

Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.

NameDesignationTerm end
RAHUL NACHANEExecutive DirectorJune 30, 2026
RAJESH LAWANDEExecutive DirectorJune 30, 2026
DHANANJAY MUNGALEIndependent DirectorJune 30, 2026
SARALA MENONIndependent DirectorJune 30, 2026
SUDHIR DEOIndependent DirectorJune 30, 2026
AJITA NACHANENon-Executive DirectorJune 30, 2026

Management, subsidiaries and brands

Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.